Biofrontera (BFRI) Gross Profit (2020 - 2025)
Historic Gross Profit for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to $4.9 million.
- Biofrontera's Gross Profit rose 1954.05% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.9 million, marking a year-over-year increase of 239.09%. This contributed to the annual value of $18.7 million for FY2024, which is 1255.19% up from last year.
- Latest data reveals that Biofrontera reported Gross Profit of $4.9 million as of Q3 2025, which was up 1954.05% from $6.4 million recorded in Q2 2025.
- Over the past 5 years, Biofrontera's Gross Profit peaked at $12.0 million during Q4 2023, and registered a low of -$7.3 million during Q4 2022.
- Moreover, its 5-year median value for Gross Profit was $4.3 million (2022), whereas its average is $4.5 million.
- Data for Biofrontera's Gross Profit shows a peak YoY increase of 26303.37% (in 2023) and a maximum YoY decrease of 20573.75% (in 2023) over the last 5 years.
- Biofrontera's Gross Profit (Quarter) stood at $9.0 million in 2021, then plummeted by 181.57% to -$7.3 million in 2022, then soared by 263.03% to $12.0 million in 2023, then tumbled by 39.02% to $7.3 million in 2024, then plummeted by 32.18% to $4.9 million in 2025.
- Its Gross Profit was $4.9 million in Q3 2025, compared to $6.4 million in Q2 2025 and $5.3 million in Q1 2025.